Clinical Trial: A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation

Saved in:
Bibliographic Details
Published inUS Fed News Service, Including US State News
Format Newsletter
LanguageEnglish
Published Washington, D.C HT Digital Streams Limited 13.10.2023
Subjects
Cholangiocarcinoma
Metastasis
Mutation
Online AccessGet full text

Cover

More Information
Description not available.